Oarsman Capital reported 3,776 shares or 0.1% of all its holdings. First Hawaiian Bank now owns 6,862 shares of the biopharmaceutical company's stock worth $505,000 after buying an additional 83 shares during the last quarter. Bristol now has $105.64B valuation. The stock declined 0.84% or $0.96 reaching $113.12 on the news. Zooming in to the past 4 weeks, shares have seen a change of 1.72%. It has underperformed by 21.16% the S&P500. The company recently announced a dividend that will be paid on Wed Nov 1, 2017.
Watching stock price activity for Bristol-Myers Squibb Company (NYSE:BMY), we have spotted shares trading close to the 64.42 level. They expect $0.75 earnings per share, down 2.60% or $0.02 from last year's $0.77 per share. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since October 23, 2016 and is downtrending. It has underperformed by 39.89% the S&P500. Jefferies Group LLC boosted their target price on shares of Bristol-Myers Squibb from $66.00 to $72.00 and gave the company a buy rating in a research note on Monday, September 11th. Therefore 46% are positive. Proficio Capital Partners LLC increased its holdings in shares of Bristol-Myers Squibb by 29.6% in the first quarter. Sandler O'Neill downgraded the stock to "Sell" rating in Thursday, January 19 report. UBS upgraded it to "Buy" rating and $75 target in Tuesday, September 29 report. BMO Capital Markets has "Sell" rating and $49.0 target. The average revenue per share growth rate of Bristol-Myers Squibb Company during the past 12 months was 15.6 percent. As per Monday, August 7, the company rating was maintained by Cowen & Co. The firm has "Hold" rating given on Thursday, June 22 by Macquarie Research.
In other news, Director Theodore R. Samuels II bought 6,000 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The rating was maintained by BMO Capital Markets on Sunday, July 23 with "Sell". Bristol-Myers Squibb has an average rating of "Hold" and an average price target of $63.79.
Analysts on average have given a price target of $59.55 to Bristol-Myers Squibb Company (BMY) stock. Burke & Herbert Retail Bank & invested in 14,732 shares or 0.75% of the stock. New England Research Inc owns 28,892 shares for 1.19% of their portfolio. The stock's price to sales ratio for trailing twelve months is 5.24 and price to book ratio for the most recent quarter is 7.21, whereas price to cash per share for the most recent quarter are 16.30. Its down 0.03, from 0.98 in 2017Q1. It dived, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. Susquehanna Int Gru Llp, a Pennsylvania-based fund reported 1.13 million shares. Bancorp Of New York Mellon Corporation invested in 0.28% or 17.52 million shares. Madison Incorporated has invested 0% in Bristol-Myers Squibb Co (NYSE:BMY). Massachusetts-based Wellington Management Gru Limited Liability Partnership has invested 1.98% in Bristol-Myers Squibb Co (NYSE:BMY). Cibc Asset Mgmt has 149,798 shares. As earnings season comes into focus, investors will be closely monitoring analyst estimates leading up to the report. Greenwood Capital Associate Ltd Liability Com holds 64,422 shares or 0.93% of its portfolio. Archford Cap Strategies Ltd Liability Corp holds 31,656 shares or 0.02% of its portfolio. Acropolis Llc holds 0.06% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 6,293 shares. Steinberg Glob Asset Mngmt reported 47,912 shares. Guardian reported 2.41% in Bristol-Myers Squibb Co (NYSE:BMY). 36,318 were accumulated by Peoples Service Corp.
The SMA20 for the stock is at 0.45 percent, SMA50 stands at 4.61 percent, while SMA200 is 14.1 Percent. Arrow Fin Corp invested in 34,135 shares. 111 funds opened positions while 598 raised stakes. (NYSE:GEF) stake by 7,960 shares and now owns 28,522 shares. Wells Fargo And Mn reported 0.01% of its portfolio in Curtiss-Wright Corp. Bangor Financial Bank accumulated 59,596 shares. Stifel Nicolaus maintained the shares of CLS in report on Wednesday, August 16 with "Hold" rating. Williams Jones And Assoc holds 0.32% or 472,595 shares in its portfolio.
08/16/2017 - Bristol-Myers Squibb Company had its "neutral" rating reiterated by analysts at Credit Suisse. Seabridge Inv Lc stated it has 0.42% of its portfolio in General Electric Company (NYSE:GE).
Investors sentiment decreased to 0.95 in Q2 2017. (NYSE:CW). Hsbc Public Limited stated it has 0% in Curtiss-Wright Corp. (NYSE:BMY) by 20.0% during the third quarter, Holdings Channel reports. Institutional investors own 68.84% of the company's stock. (NYSE:CW) for 211 shares.
Eastern Bank decreased I Shares (CIU) stake by 5,832 shares to 30,819 valued at $3.38M in 2017Q2. It also upped Delta Air Lines Inc (NYSE:DAL) stake by 9,196 shares and now owns 46,748 shares. Vanguard Intermediate Term Cor Etf (VCIT) was reduced too.
Receive Bristol-Myers Squibb Company News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol-Myers Squibb Company with MarketBeat.com's FREE daily email newsletter.
- Train Derailment clean up continues in Sturgeon County
- Cisco Systems (NASDAQ:CSCO) Earns Daily News Impact Rating of 0.15
- Trump Awards Medal of Honor to Vietnam Army Medic
- Singapore Airlines inks deal with Boeing worth 13.8 bln United States dollars
- Pixel 2 XL POLED display has massive Burn-In issue
- Brokers Issue New Targets On Pepsico, Inc. (NYSE:PEP)
- Cabot Oil & Gas Corporation (NYSE:COG) Underpriced by 13.9%?
- Seattle Genetics (SGEN) Receiving Somewhat Positive Press Coverage, Analysis Finds
- Arconic names veteran GE exec Blankenship as CEO
- Olympic gymnast Shawn Johnson shares heartbreaking story of miscarriage in video